Exit interviews were conducted with caregivers of individuals with Rett syndrome (RTT) participating in open-label trofinetide studies to gain insight into the patient experience of RTT and trofinetide treatment.
No takes yet. Share an insight, caveat, or question.
Bishop et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: